CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Operating expenses
Research and development	$ 513,004	$ 67,291	$ 1,522,031	$ 92,291
General and administrative	990,110	978,329	3,267,037	3,284,880
Total operating expenses	1,503,114	1,045,620	4,789,068	3,377,171
Operating loss	(1,503,114)	(1,045,620)	(4,789,068)	(3,377,171)
Other expense (income)
Change in fair value of derivative liabilities	3,126,464	1,050,729	(2,024,660)	1,653,477
Fair value of derivative liabilities in excess of proceeds			322,644	7,174,634
Financing transaction costs				137,192
Loss on extinguishment of secured convertible promissory note - related party				590,392
Interest expense	301,547	0	711,575	37,708
Interest income				(74)
Total other expense (income)	3,428,011	1,050,729	(990,441)	9,593,329
Loss before income taxes	(4,931,125)	(2,096,349)	(3,798,627)	(12,970,500)
Provision for income taxes	0	0	1,600	1,642
Net Loss and comprehensive loss	$ (4,931,125)	$ (2,096,349)	$ (3,800,227)	$ (12,972,142)
Loss per common share:
Basic (in dollars per share)	$ (0.04)	$ (0.02)	$ (0.03)	$ (0.11)
Diluted (in dollars per share)	$ (0.04)	$ (0.02)	$ (0.03)	$ (0.11)
Weighted average shares of common stock outstanding used to compute earnings per share:
Basic (in shares)	133,001,746	131,445,057	132,885,675	117,434,563
Diluted (in shares)	133,001,746	131,445,057	167,690,989	117,434,563